Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin)...